ステージ
ホーム > 研究と業績 > 論文 2020年

論文 2020年

論文バックナンバー

2020年

英文

  1. Miyazaki T, Yanagihara K, Kakeya H, Izumikawa K, Mukae H, Shindo Y, Yamamoto Y, Tateda K, Tomono K, Ishida T, Hasegawa Y, Niki Y, Watanabe A, Soma K, Kohno S. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study. J Infect Cheomother, 26:242-251, 2020
  2. Tsubouchi T, Suzuki M, Niki M, Oinuma K, Niki M, Kakeya H, Kaneko Y. Complete genome sequence of Acinetobacter baumannii ATCC19606T, which is a model strain of pathogenic bacteria causing nosocomial infection. Microbiology Resource Announcements, 2020
  3. Moriguchi M, Koh H, Hayashi T, Okamura H, Nanno S, Nakashima Y, Nakane T, Imoto W, Yamada K, Kakeya H, Hino M, Nakamae H. Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia. J Infection Chemother, 2020, accepted
  4. Shibata W, Niki M, Sato K, Fujimoto H, Yamada K, Watanabe T, Miyazaki Y, Asai K, Obata Y, Tachibana T, Kawaguchi T, Kaneko Y, Kakeya H. Detection of Rhizopus-specific antigen in human and murine serum and bronchoalveolar lavage. Med Mycol. 2020 Oct 1;58(7):958-964. doi: 10.1093/mmy/myaa001.
  5. Kuwabara G, Yukawa S, Koichi Yamada K, Imoto W, Yamairi K, Shibata W, Yoshii N, Watanabe T, Asai K, Niki M, Nakaie K, Okada Y, Fujita A, Kaneko Y, Kawaguchi T, Kakeya H. The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia. Anaerobe, 2020, 64:102214. doi: 10.1016/j.anaerobe.2020.102214. Epub 2020 May 21.
  6. Imoto W, Yamada K, Hajika Y, Okamoto K, Myodo Y, Niki M, Kuwabara G, Yamairi K, Shibata W, Yoshii N, Nakaie K, Yoshizawa K, Namikawa H, Watanabe T, Asai K, Moro H, Kaneko Y, Kawaguchi T, Ito Y, KakeyaH. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good’s syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: A case report, BMC Infect Dis, 20:431, 2020
  7. Yoshii N, Tochino Y, Fujioka M, Sakazaki H, Maruyama N, Asai K, Kakeya H, Shintaku H, Kawaguchi T. The comparison of the efficacy of baloxavir and neuraminidase inhibitors for patients with influenza A in clinical practice. Intern Med 2020; 59:1509-1513.
  8. Takizawa E, Fujimoto H, Namikawa E, Yamada K, Yamairi K, Shibata W, Kakeya H. A case of Fabry disease in heterozygous female diagnosed by Mulberry body. Risho Byori, 2020, accepted.
  9. Murakami T, Tokuda T, Nishimura S, Fujii H, Takahashi Y, Yamane K, Inoue K, Yamada K, Kakeya H, Toshihiko Shibata T. Successful treatment of Staphylococcus schleiferi infection after aortic arch repair: In situ aortic arch replacement and domino reconstruction of the debranching graft using autologous iliac artery. Acta Med. Okayama, 2020;74(3):251-255.
  10. Harada N, Shibata W, Koh H, Takashita E, Fujisaki S, Okamura H, Nanno S, Yamada K, Nakamae H, Hino M, Kakeya H. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: A case report. BMC Infect Dis, 2020, accepted
  11. Yamada K, Kuwabara G, Imoto W, Yamairi K, Shibata W, Oshima K, Yoshii N, Nakaie K, Niki M, Okada Y, Fujita A, Sakurai N, Kaneko Y, Kakeya H. Blood culture reports by infectious disease physicians can improve the prognosis of bacteremia, including in cases of weekend onset. Intern J Infect Dis, 2020 Nov;100:174-179. doi: 10.1016/j.ijid.2020.08.013. Epub 2020 Aug 8.
  12. Moriguchi M, Koh H, Hayashi T, Oakmura H, Nanno S, Nakashima Y, Nakane T, Imonoto W, Yamada K, Kakeya H, Hino M, Nakamae H. Clinical usefulness of very high serum soluble interleukin-2 receptor level for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia. J Infect Chemoter, 2020, in press
  13. Yanagihara K, Matsumoto T, Tokimatsu I, Tsukada H, Fujikura Y, Miki M, Morinaga Y, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Fujiuchi S, Takahashi M, Kayaba H, Mori Y, Takeda H, Ikeda H, Takahashi H, Konno M, Niitsuma K, Niki Y, Takuma T, Kawana A, Kudo M, Hirano T, Miyazawa N, Aso S, Aoki N, Honma Y, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Kondo S, Kawabata A, Sugaki Y, Yamamoto T, Nishi I, Hamaguchi S, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Yoshida K, Hayashia M, Mikasaa K, Kasahara K, Tokuyasu H, Hino S, Shimizu E, Chikumi H, Fujita M, Kadota J, Hiramatsu K, Suga M, Muranaka H. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese society of chemotherapy, the Japanese association for infectious diseases, and the Japanese society for clinical microbiology in 2016: General view of the pathogens’ antibacterial susceptibility. J Infect Chomother 2020:26, 873-881.
  14. Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia. Intern Med, 59:193-198, 2020
  15. Imoto W, Kaga S, Noda T, Mizobata Y, Kakeya H. Coronavirus disease with multiple infarctions. QJM 2020, 1;113(12):907-908. doi: 10.1093/qjmed/hcaa240.
  16. Imoto W, Arima H, Yamada K, Kanzaki T, Nakagawa C, Kuwabara G, Yamiri K, Sjibata W, Oshima K, Watanbe T, Asai K, Kaneko Y, Kawaguchi T, Goto T, Kakeya H. Incidental finding of neurosyphilis with intracranial hemorrhage and cerebral infarction: A case report. J Infect Chemother, 2020 Oct 14;S1341-321X(20)30360-3. doi: 10.1016/j.jiac.2020.10.001. Online ahead of print.
  17. Izumikawa K, Kakeya H, Sakai F, Shibuya K, Sugita T, Takazono T, Takata T, Tashiro M, Teruya K, Nakamura S, Noguchi H, Hiruma M, Makimura K, Miyazaki T, Miyazaki Y, Yamagishi Y, Yoshida K, Watanabe A. Executive summary of JSMM clinical practice guidelines for diagnosis and treatment of cryptococcosis 2019. Med Mycol J, 61, 61-89, 2020
  18. Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota J, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A. Clinical manifestations of adult patients requiring influenza associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother 2020, accepted
  19. Imoto W, Kaneko Y, Yamada K, Kuwabara G, Yamairi K, Shibata W, Oshima K, Niki M, Nakaie K, Watanabe T, Asai K, Kawaguchi T, Kakeya H. A mouse model of rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia. J Glob Antimicrob Resist, 2020, Online ahead of print.

和文

  1. 掛屋 弘. ESBL, KPC, NDMなどのβラクタマーゼ産生菌. 今日の治療指針2020. 医学書院 2020, pp218-219.
  2. 中村安孝, 山田康一, 掛屋 弘, 永山勝也. 薬剤の使用動向の指標を用いて薬剤師がすべき薬剤耐性菌対策. 日化療会誌 68, 123-131, 2020.
  3. 掛屋 弘. 医学と医療の最前線 肺真菌症の臨床. 日内会誌 109, 293-299,2020
  4. 掛屋 弘. 肺真菌症(肺アスペルギルス症、肺クリプトコックス症)の疫学、病態、診断、治療. 呼吸器ジャーナル 呼吸器感染症診療の最前線. 68(2), 270-278, 2020
  5. 掛屋 弘. 肺真菌症. 今日の診断指針第8版. 医学書院, 東京, 2020, pp948-950.
  6. 大島一浩, 桑原 学, 井本和紀、山入和志, 柴多 渉, 山田康一, 切通絢子, 加賀慎一郎, 西村哲郎, 溝端康光, 掛屋 弘. ヒドロキシクロロキン、アジスロマイシン、ファビピラビルによる治療中に心室細動を起こしたCOVID-19肺炎の一例. 日本感染症学会HP,新型コロナウイルス肺炎(COVID-19)の緊急症例報告, 2020年4月24日公開
  7. 柴多 渉, 掛屋 弘. 慢性肺アスペルギルス症の治療方針は? 竹末芳生編. AST虎の巻:日常の疑問に答える! 中外医学社, 東京. 2020, pp109-115.
  8. 柴多 渉、掛屋 弘. 薬剤耐性カンジダの疫学. 臨床検査 2020;64(7):772-777.
  9. 山田康一、掛屋 弘. ICTから現場へ! カルバペネム系薬の使用が減らない! Infection Control 夏季増刊, 2020:152-158.
  10. 掛屋 弘. 大阪における新型コロナウイルス感染症 これまでの動向. ヴァンメディカルHP掲載
  11. 掛屋 弘. 十三市民病院のコロナ専門病院としての出発に寄せて. 新型コロナウイルス感染症「COVID-19」対応BOOK. 照林社. 2020: 4-5.
  12. 掛屋 弘. 慢性肺アスペルギルス症-治療のポイント. 日本医事新報 2020; 5039: 25-32.
  13. 安部順子、山田康一、吉井直子、柴多 渉、大島一浩、掛屋 弘. 週3回透析患者に対する抗MRSA薬ダプトマイシン投与のシミュレーション-週3回透析後投与において週末に1.5倍量投与は妥当か?-. 臨床薬理2020;51(6):325-330.
  14. 掛屋 弘. 新型コロナ第3波 大阪府の現状―大阪府は「赤信号」、求められるのは「人」. ヴァンメディカル掲載(https://www.kansentaisaku.jp/2020/12/1806/
  15. 掛屋 弘. (どうしました)耐性菌家族への感染心配. 2020年10月7日付 朝日新聞掲載
  16. 掛屋 弘, 柴多 渉. 薬剤耐性真菌の現状. 感染症 50(5), 2020
    https://amn-s.astellas.jp/EM/WW/?p=4748e8592ca2fcf0d0174cdce3c5e8f9
サイドメニューコンテンツ

ILOHA

研修医のための感染症予備校